ArticleSisli Etfal Hastanesi tip bulteni2026
Comparative Utility of Body Fat and Visceral Fat Measured by Bioimpedance Versus BMI and Waist Circumference in Predicting Elevated Cardiovascular Risk Scores.
Article in Sisli Etfal Hastanesi tip bulteni, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Obesity is a key modifiable risk factor for cardiovascular disease (CVD), yet the most effective anthropometric index for identifying individuals at elevated cardiovascular risk (CVR) remains debated. Body fat (BF) and visceral fat (VF) measured by bioimpedance may provide greater discriminatory capacity than body mass index (BMI) or waist circumference (WC) when applied to validated CVR scales. To compare the predictive performance of BF and VF with BMI and WC for identifying elevated CVR according to Framingham vascular age, SCORE vascular age, and SCORE2 in a large occupational cohort. Methods: This cross-sectional study included 8,590 Spanish workers (52.2% women) who were evaluated between 2021 and 2023 during routine occupational health assessments. Anthropometric measures included BMI and WC, while BF and VF were obtained through validated bioelectrical impedance analysis. Elevated CVR was defined according to the thresholds of each scale. Predictive capacity was assessed using receiver operating characteristic (ROC) curves and area under the curve (AUC) values with 95% confidence intervals (CIs). Results: In women, VF showed the highest AUC for Framingham vascular age (0.828; 95% CI: 0.808-0.849) and SCORE vascular age (0.779; 95% CI: 0.755-0.804), whereas WC performed slightly better for SCORE2 (0.647; 95% CI: 0.629-0.666). BF achieved moderate accuracy across all scales (AUC: 0.640-0.794), while BMI consistently yielded the lowest values (AUC: 0.607-0.749). In men, BF had the highest AUC for Framingham vascular age (0.799; 95% CI: 0.775-0.823), VF was superior for SCORE vascular age (0.768; 95% CI: 0.749-0.787), and all indices showed lower discrimination for SCORE2 (AUC range: 0.611-0.624). Conclusion: BF and VF measured by bioimpedance demonstrated higher predictive capacity for elevated CVR than BMI or WC in both sexes, although the best-performing index varied by scale and sex. These findings support the inclusion of direct adiposity measurements in occupational health screening to improve the early detection of cardiovascular risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.